Sequence of testing for monoclonal gammopathies

Area of Science:

• Clinical Chemistry
• Hematology
• Immunology

Background:

• Monoclonal gammopathies are a group of disorders characterized by the production of a monoclonal immunoglobulin (M-protein).
• Early and accurate diagnosis is essential for effective management and treatment of these conditions.

Purpose of the Study:

• To outline the recommended diagnostic algorithm for the recognition and evaluation of monoclonal gammopathies.
• To emphasize the roles of key laboratory tests in identifying and characterizing M-proteins.

Main Methods:

• Serum protein electrophoresis (SPEP) using high-resolution agarose gel is the primary screening test.
• Immunofixation electrophoresis (IFE) is used to differentiate monoclonal from polyclonal immunoglobulin increases.
• Quantitation of immunoglobulins via rate nephelometry and measurement of serum viscosity are indicated in specific clinical scenarios.
• 24-hour urine protein excretion and urine IFE are essential for detecting light chain involvement and confirming diagnosis.

Main Results:

• SPEP is the initial test for suspected monoclonal gammopathies, including multiple myeloma, Waldenström's macroglobulinemia, and primary amyloidosis.
• IFE is critical for confirming the monoclonal nature of immunoglobulins identified by SPEP.
• Urine immunofixation is recommended for patients with significant serum M-protein levels or suspected related disorders.

Conclusions:

• A systematic approach utilizing SPEP, IFE, and urine protein analysis is vital for diagnosing monoclonal gammopathies.
• These laboratory tests aid in differentiating between various related disorders and guiding appropriate patient management.